What’s Next For Stem Cells?

Law360, New York (May 4, 2009, 12:00 AM EDT) -- President Obama’s lifting of the ban on federally funded stem cell research, cheered by activists and researchers, draws even more mainstream attention to a field many companies and investors are watching closely.

While unlocking federal funds has rightfully been described as the throttle U.S. research and development departments needed to develop new cures and treatments and help U.S. pharmaceuticals and health care institutions compete on the world stage, it serves a greater purpose by shifting the spotlight to issues that are arguably even more important for...
To view the full article, register now.